As of Oct 09
| +0.28 / +7.57%|
The 3 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +201.51% increase from the last price of 3.98.
The current consensus among 3 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.